Phase I study of the aurora A kinase inhibitor alisertib with induction chemotherapy in patients with acute myeloid leukemia
Fathi, Amir T., Wander, Seth A., Blonquist, Traci M., Brunner, Andrew M., Amrein, Philip C., Supko, Jeffrey, Hermance, Nicole M., Manning, Amity L., Sadrzadeh, Hossein, Ballen, Karen K., Attar, Eyal CVolume:
102
Langue:
english
Journal:
Haematologica
DOI:
10.3324/haematol.2016.158394
Date:
April, 2017
Fichier:
PDF, 503 KB
english, 2017